about
Learning multiple evolutionary pathways from cross-sectional data.Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies.Genotypic tropism testing by massively parallel sequencing: qualitative and quantitative analysis.Full-length haplotype reconstruction to infer the structure of heterogeneous virus populations.Read length versus depth of coverage for viral quasispecies reconstructionThe L76V mutation in HIV-1 protease is potentially associated with hypersusceptibility to protease inhibitors Atazanavir and Saquinavir: is there a clinical advantage?HIV-1 tropism testing in subjects achieving undetectable HIV-1 RNA: diagnostic accuracy, viral evolution and compartmentalization.Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case-control study using centralized ultrasensitive 454 pyrosequencing.Geno2pheno: Estimating phenotypic drug resistance from HIV-1 genotypesComputational methods for the design of effective therapies against drug resistant HIV strains.Selective pressures of HLA genotypes and antiviral therapy on human immunodeficiency virus type 1 sequence mutation at a population level.Deep sequencing reveals mutagenic effects of ribavirin during monotherapy of hepatitis C virus genotype 1-infected patients.Next-generation sequencing to assess HIV tropism.Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.Prediction of HIV-1 coreceptor usage (tropism) by sequence analysis using a genotypic approach.Short communication: selection of thymidine analogue resistance mutational patterns in children infected from a common HIV type 1 subtype G source.Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing.Analysis of immune selection as a potential cause for the presence of cleavage site mutation 431V in treatment-naive HIV type-1 isolates.In-depth analysis of G-to-A hypermutation rate in HIV-1 env DNA induced by endogenous APOBEC3 proteins using massively parallel sequencing.Evolution of protease inhibitor resistance in the gag and pol genes of HIV subtype G isolates.A novel internally controlled real-time reverse transcription-PCR assay for HIV-1 RNA targeting the pol integrase genomic region.Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.Successful therapy of hepatitis B with tenofovir in HIV-infected patients failing previous adefovir and lamivudine treatment.Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.Functional domains of the human immunodeficiency virus type 1 Nef protein are conserved among different clades in Cameroon.Evolution of raltegravir resistance during therapy.Short communication: Different mutation patterns in subtype CRF06_cpx after mother-to-child transmission.Estimating HIV evolutionary pathways and the genetic barrier to drug resistance.
P50
Q31000631-A0402E7F-F40C-4F90-9605-6462EEDDB184Q33645217-9B55F3B6-79F1-4BA1-BE1B-81A55C5C4668Q33899080-1C6A13A3-6A26-4CAF-B495-C7A8442C2428Q34044256-C89084E3-E8E8-4017-878D-7CCF02CFD31DQ34442752-70D23F4D-D35B-4DD4-840B-0C9500631E14Q34626108-47EADDB5-D8F5-402C-80EF-41234FB101B2Q34923915-3934B9C1-5658-4B10-8C01-F17D3537FF3EQ35056873-31764508-02D0-47AA-B177-1D419EC017FAQ35208107-0BA0AFE6-F2F3-4355-A545-058B635FA0E6Q36250187-FA56B5FB-D9A8-4798-9803-BD671615D3BCQ36313428-3069D458-4703-4CF0-ACE9-6A77D3B6138FQ36827155-DE3E72F3-957A-4D90-BBB3-3931FA58D4E5Q38029501-7031CB14-D267-4A1B-8357-AE1484D3EA73Q38887171-2A41D4F3-9D6A-44F0-B08B-E03987D6730DQ38951030-DBAC7637-6CE2-4FD8-A48A-2D6B6241C186Q42186680-9F542775-115E-4E34-97E2-D72C9AC90D1BQ43119918-93D9AD70-F012-4A10-844A-50BA2D9446BCQ43637908-ADD54BF0-03C2-46AA-8638-7F0678055873Q43924336-56CD7139-4437-4B8D-8533-441BB284E38CQ44197028-BF1FBDAB-7063-46B8-B6AD-31745F6BC566Q44421216-E49F44A8-C7EA-4DF9-B9AF-AABD16025F68Q44851839-7D947806-4325-46C1-A6AB-47B3027AFE92Q45026495-0D69F1BA-375C-4599-931D-290192E62CBFQ45172160-213DA130-2198-4E58-B8B2-93B2C7280749Q45409665-FE85B6C0-45A5-4E01-8648-570E382DF1A6Q45410653-BA184737-53F6-4ECD-B332-CA6C81F3A68DQ46008671-21502C75-1565-4F47-86B7-251891A905B1Q46229848-89942622-FB35-4346-AE7F-F57F8EF43FC8Q46472009-D1314714-3005-430D-A798-9B57DD274444
P50
name
Martin Däumer
@ast
Martin Däumer
@en
Martin Däumer
@es
Martin Däumer
@fr
Martin Däumer
@nl
type
label
Martin Däumer
@ast
Martin Däumer
@en
Martin Däumer
@es
Martin Däumer
@fr
Martin Däumer
@nl
prefLabel
Martin Däumer
@ast
Martin Däumer
@en
Martin Däumer
@es
Martin Däumer
@fr
Martin Däumer
@nl